Elevance Health
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $49,776,000 | $48,891,000 | $45,442,000 | $45,145,000 |
Gross Profit | 49,776,000 | 48,891,000 | 45,442,000 | 45,145,000 |
EBITDA | 3,013,000 | 3,514,000 | 1,344,000 | 2,002,000 |
EBIT | 2,633,000 | 3,141,000 | 946,000 | 1,673,000 |
Net Income | 1,743,000 | 2,183,000 | 418,000 | 1,016,000 |
Net Change In Cash | 49,776,000 | 48,891,000 | 45,442,000 | 45,145,000 |
Free Cash Flow | 1,787,000 | 821,000 | 384,000 | 2,345,000 |
Cash | 8,560,000 | 7,500,000 | 8,288,000 | 7,866,000 |
Basic Shares | 225,800 | 227,200 | 231,100 | 233,100 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $176,810,000 | $171,340,000 | $156,595,000 | $138,639,000 |
Gross Profit | 176,810,000 | 171,340,000 | 156,595,000 | 138,639,000 |
EBITDA | 10,482,000 | 10,490,000 | 10,126,000 | 10,095,000 |
EBIT | 9,089,000 | 8,745,000 | 8,451,000 | 8,793,000 |
Net Income | 5,980,000 | 5,987,000 | 5,894,000 | 6,158,000 |
Net Change In Cash | 176,810,000 | 171,340,000 | 156,595,000 | 138,639,000 |
Cost of Revenue | 2,521,000 | -861,000 | ||
Free Cash Flow | 4,552,000 | 6,765,000 | 7,247,000 | 7,277,000 |
Cash | 8,288,000 | 6,526,000 | 7,387,000 | 4,880,000 |
Basic Shares | 232,900 | 237,400 | 242,800 | 246,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $7.72 |
2025-03-31 | $11.97 |
2024-12-31 | $3.84 |
2024-09-30 | $8.37 |
